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A major challenge in the study of gene regulation by NF-kByRel
transcription factors is to understand, at the biological and mech-
anistic levels, the selective functions of individual Rel family
members. To study selectivity, we have examined the NF-kByRel
protein binding site (Rel site) within the IL-12 p40 promoter. IL-12
is a proinflammatory cytokine expressed by activated macro-
phages that serves as an essential inducer of T helper 1 cell
development. In nuclear extracts from lipopolysaccharide-
activated macrophages, the predominant Rel dimers capable of
binding the IL-12 p40 Rel site were the p50yp65 and p50yc-Rel
heterodimers and p50yp50 homodimer. The two heterodimers
bound the site with comparable affinities and exhibited compara-
ble transactivation activities. In striking contrast, p40 mRNA and
protein concentrations were reduced dramatically in c-Rel2/2 mac-
rophages and only modestly in p652/2 macrophages. Other proin-
flammatory cytokine mRNAs and proteins were not significantly
reduced in c-Rel2/2 macrophages. These results reveal that a
c-Rel-containing complex is an essential and selective activator of
p40 transcription, which may reflect unique regulatory mecha-
nisms or biological functions of IL-12. Furthermore, because selec-
tivity was not observed in vitro or in transient transactivation
experiments, these findings suggest that an understanding of the
selectivity mechanism may require an analysis of the endogenous
p40 locus.
Macrophages are among the first lines of defense in responseto pathogenic infection. After the interaction of a patho-
gen with receptors on the macrophage surface, numerous cel-
lular genes are induced, several of which encode cytokines that
stimulate an inflammatory response (1). IL-12 is unique among
the proinflammatory cytokines produced by activated macro-
phages because it serves as an essential inducer of T helper 1 cell
development and thus provides a bridge between innate and
adaptive immunity (2). T helper 1 cells are required for a
cell-mediated immune response, which contributes to the sup-
pression or elimination of numerous intracellular pathogens (2).
Biologically active IL-12 p70 is composed of two subunits, p40
and p35, both of which are induced in macrophages and dendritic
cells at the level of transcription (3). In transfection assays, the
promoter for the p40 gene is strongly induced by lipopolysac-
charide (LPS) and other bacterial products (4–6). Multiple DNA
elements contribute to promoter activity, including an element
that binds members of the NF-kByRel family of transcription
factors (4, 6). Rel binding sites have been identified in the
promoters for several other proinflammatory cytokine genes
expressed in macrophages, including the IL-1b, IL-6, and tumor
necrosis factor a (TNF-a) genes (7–10).
Five Rel family members have been identified in mammalian
cells: p50, p65 (RelA), c-Rel, p52, and RelB (7). These proteins
exist in various homodimeric and heterodimeric complexes that
often are maintained in an inactive state by cytoplasmic asso-
ciation with I-kB proteins (7). Cell activation leads to a signal
transduction cascade that results in the phosphorylation and
degradation of the I-kBs, allowing nuclear translocation and
DNA binding of the Rel dimers.
The presence of five Rel family members suggests that each
family member and each dimeric complex might regulate unique
sets of genes. The strongest evidence for unique functions has
been provided by analyses of mice that are deficient for indi-
vidual family members. Each deficiency results in a different
phenotype, suggesting that unique target genes must exist (7).
Nevertheless, redundancy and compensation among family
members have made it difficult to identify specific target genes
and determine the mechanism of family-member selectivity. This
analysis is further complicated by the embryonic lethality of
p652/2 mice and the inherent challenge of distinguishing direct
from indirect effects. Despite these challenges, analyses of
Rel-deficient mice have revealed genes that require a specific
family member for expression. For example, c-Rel2/2 mice do
not express the IL-2, A1, and interferon regulatory factor-4
genes in at least some cell types and express the IL-3, granulo-
cyte—macrophage colony-stimulating factor (GM-CSF), induc-
ible nitric-oxide synthase (i-NOS), and TNF-a genes at reduced
levels (11–15).
Additional insight into the unique properties of Rel family
members has been provided by biochemical studies. For exam-
ple, although the DNA sequences preferred by the various Rel
dimers are similar, differences have been observed that may
contribute to family member selectivity (16). Studies of numer-
ous cellular promoters have revealed selective DNA binding and
transactivation by specific Rel dimers. However, when dimers
with similar sequence preferences were compared, such as the
p50yp65 and p50yc-Rel heterodimers, the comparisons usually
were performed in the absence of appropriate controls to ensure
that equivalent concentrations of the two heterodimers were
being analyzed. Thus, the mechanistic basis of family member
selectivity remains unresolved, in particular for closely related
dimers.
In this study, we have examined the Rel protein interactions
at the murine IL-12 p40 promoter and the Rel requirements for
p40 transcription. p50yc-Rel and p50yp65 heterodimers were
equivalent in their capacity to bind and transactivate the p40
promoter in DNA-binding and transient transactivation assays.
However, an analysis of macrophages from Rel mutant mice
revealed that a c-Rel-containing complex is essential for activa-
tion of the endogenous p40 gene. The implications of these
results for elucidating the mechanism and relevance of family
member selectivity within the mammalian immune system are
discussed.
Materials and Methods
Cells and Transfections. The J774 and 293T lines (American Type
Culture Collection) were grown in DMEM containing 10% FBS.
Abbreviations: LPS, lipopolysaccharide; fc-Rel, Flag-tagged c-Rel; fp65, Flag-tagged p65;
TNF-a, tumor necrosis factor a.
§To whom reprint requests should be addressed. E-mail: steves@hhmi.ucla.edu.
The publication costs of this article were defrayed in part by page charge payment. This
article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C.
§1734 solely to indicate this fact.
Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073ypnas.230436397.
Article and publication date are at www.pnas.orgycgiydoiy10.1073ypnas.230436397
PNAS u November 7, 2000 u vol. 97 u no. 23 u 12705–12710
IM
M
U
N
O
LO
G
Y
J774 cells were activated by IFN-g (10 unitsyml) and LPS (10
mgyml). 293T cells were transfected by using a calcium phos-
phate procedure (17). Expression plasmids for murine p50,
c-Rel, p65, and Flag-tagged c-Rel (fc-Rel) were from Ranjan Sen
(Brandeis University, Waltham, MA). Flag-tagged p65 (fp65)
was constructed by inserting the Flag epitope sequence at the 59
end of the murine p65 cDNA in pcDNA3 (Invitrogen). The p40
promoter-luciferase reporter plasmid was described (6).
Peritoneal exudate cells were isolated as described (18).
Before performing experiments, cells were harvested and re-
plated at appropriate densities. Fetal liver macrophages were
prepared from day 14.5 embryos. Cells (1 3 106yml) were plated
in DMEM with 30% L929-conditioned medium, 20% FBS, 1%
L-glutamine, 0.5% sodium pyruvate, and 0.1% b-mercaptoetha-
nol. The cells were cultured for 7 days, with fresh medium added
as necessary.
Gel Shift Assays. Nuclear extracts and gel shift probes were
prepared as described (6). The gel shift probe contained the p40
promoter sequence from 2142 to 2107 (4, 6). Gel shift assays
were performed as described (4, 6). Antibodies from Santa Cruz
Biotechnology were: p50 (D-17), p65 (A), c-Rel (C), RelB
(C-19)X, and p52(K-27)X. Protein-DNA complexes were ana-
lyzed on a 5% polyacrylamidey0.43 Tris-borate-EDTA gel.
Immunoprecipitations. The p50 antibody (4 mg; D-17, Santa Cruz
Biotechnologies) was added to nuclear extracts (50 mg) from
293T cells in 100 ml of NETN buffer (100 mM NaCly1 mM
EDTAy20 mM Tris, pH 8y0.5% Nonidet P-40). The solution was
incubated on ice for 30 min and at room temperature for 5 min.
Protein G-Sepharose beads (25 ml) were added, and the mixture
was agitated at 4°C for 1 h. After centrifugation, the supernatant
was saved and the pellet was washed four times with RIPA (150
mM NaCly50 mM Tris, pH 7.5y0.025% deoxycolate Na1y1%
Nonidet P-40). Samples were analyzed on a 10% SDS-
polyacrylamide gel. Western blots were performed by using
anti-f lag M2 monoclonal antibody (Kodak) and anti-p50 (H-
119)X antibody (Santa Cruz Biotechnologies).
ELISA. A total of 2 3 106 cells were cultured in 3 ml of DMEM
(plus 10% FBS) and activated with LPSyIFN-g for 24 h. Then,
100 ml of the supernatants and 10-fold serial dilutions were tested
by sandwich ELISA. IL-1b was detected in cell extracts. Purified
rat anti-mouse IL-12 p40yp70 and IL-6, biotin anti-mouse IL-12
p40yp70 and IL-6, recombinant mouse IL-12 and IL-6, and IL-10
and TNF-a (monoypoly) ELISA kits were from PharMingen.
Monoclonal anti-mouse IL-1b, biotin anti-mouse IL-1b, and
recombinant murine IL-1b were from R & D Systems.
RNase Protection. Primary macrophages were cultured in 100-mm
tissue culture dishes in 10 ml DMEM containing 10% FBS and
were activated with LPSyIFN-g for 4 h. Total RNA was prepared
by using TRI REAGENT (Molecular Research Center, Cincin-
nati). Then, 1–5 mg of the RNAs were analyzed by using RNase
protection kits (PharMingen).
Results
Rel Interactions at the p40 Promoter in Vitro. As a first step toward
identifying the Rel dimer responsible for p40 activation, we
determined which dimers can form stable gel shift complexes
with a probe containing the Rel site from the p40 promoter.
Homodimers and heterodimers containing the murine p50, p65,
and c-Rel proteins were prepared by transfection of 293T cells
with expression plasmids. Abundant gel shift complexes were
detected with extracts containing overexpressed p50, p50 plus
p65, and p50 plus c-Rel (Fig. 1A). The lower complexes corre-
spond to p50 homodimers (see below). The upper complexes in
lanes 5 and 6 correspond to p50yp65 and p50yc-Rel het-
erodimers, respectively. Abundant complexes were not detected
when p65 and c-Rel were overexpressed individually or together
(lanes 3, 4, and 7).
The effects of Rel antibodies were determined to confirm the
identities of the complexes and demonstrate the specificity of the
antibodies used for this study. A p50 antibody supershifted both
the lower and upper complexes obtained with extracts contain-
ing p50 plus p65 and p50 plus c-Rel (Fig. 1B, lanes 2 and 6). (The
band comigrating with the p50yp65 complex in lane 2 was not
typically observed.) A p65 antibody abolished the upper complex
obtained with the p50 plus p65 extract, but had no effect on the
complexes obtained with the p50 plus c-Rel extract (Fig. 1B,
lanes 3 and 7). A c-Rel antibody elicited the opposite effect
(lanes 4 and 8). These results confirm the assignments of the gel
shift complexes and the antibody specificities. It is worth noting
that the p50yc-Rel dimer consistently yielded a diffuse complex,
in contrast to the sharp p50yp65 complex (Fig. 1B, lanes 1 and 5).
To determine which complexes are detectable with nuclear
extracts from p40-expressing cells, the J774 macrophage line was
used. This line produces substantial quantities of p40 mRNA
after LPS activation (18). Gel shift analyses with J774 nuclear
extracts from unactivated and activated cells revealed the in-
duction of two complexes (Fig. 1C, lanes 1 and 2). Antibodies to
p50 supershifted both complexes (lane 3), suggesting that the
lower complex contains p50 homodimers and the upper com-
plex, one or more p50-containing heterodimers. Antibodies to
p65 abolished the sharp upper complex, but a weak, diffuse
complex reminiscent of the p50yc-Rel heterodimer was retained.
This diffuse complex appeared to be abolished by c-Rel anti-
bodies, with the sharp p50yp65 complex retained (lane 5).
Fig. 1. Three Rel dimers bind the p40 Rel site in vitro. (A) Gel shift assays were performed with nuclear extracts (4 mg) from 293T cells containing overexpressed
Rel proteins as indicated. (B) Gel shift assays were performed with extracts containing overexpressed p50yp65 (lanes 1–4) and p50yc-Rel (lanes 5–8). Specific
antibodies were included as indicated. (C) Gel shift assays were performed with extracts (8 mg) from unactivated (lane 1) or LPSyIFN-g-activated (lanes 2–8) J774
cells.
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Simultaneous addition of p65 and c-Rel antibodies abolished
both the sharp and diffuse complexes (lane 8). Commercial
antibodies to RelB and p52 had no effect on these complexes
(lanes 6 and 7). These results demonstrate that three gel shift
complexes can be detected with extracts from activated J774
cells: p50yp65 and p50yc-Rel heterodimers and p50yp50 ho-
modimers. Similar results were obtained with extracts from
peritoneal macrophages (see Fig. 4C).
Comparable DNA-Binding Affinities of p50yc-Rel and p50yp65. To
help identify the Rel activator of p40 transcription, the relative
affinities of the p50yp65 and p50yc-Rel heterodimers for the p40
Rel site were determined. For this comparison, extracts con-
taining the heterodimers at comparable concentrations were
prepared by overexpressing in 293T cells Flag-tagged versions of
c-Rel and p65 (fc-Rel and fp65). Fig. 2A shows Western blot
results obtained with three different amounts of a pair of extracts
that contain comparable concentrations of fc-Rel and fp65.
Next, coimmunoprecipitation experiments were performed to
establish that the extracts contained comparable concentrations
of the p50yfc-Rel and p50yfp65 heterodimers, not just compa-
rable concentrations of fc-Rel and fp65. Immunoprecipitation
with p50 antibodies resulted in the efficient removal of fp65 and
fc-Rel (Fig. 2B, lanes 17–20; lanes 1–16 serve as controls),
demonstrating that almost all of the fp65 and fc-Rel molecules
existed as stable heterodimers with p50.
To compare the relative affinities of the p50yfc-Rel and
p50yf65 heterodimers for the p40 Rel site, gel shift experiments
were performed with equivalent amounts of each extract, re-
sulting in p50yp65 and p50yc-Rel complexes of comparable
abundance (Fig. 2C, compare lanes 7 and 14). As in Fig. 1, the
p50yc-Rel complex was diffuse. However, on quantitation by
phosphorimager analysis, this complex was found to contain a
similar amount of radioactivity as the p50yp65 complex (581 and
562 arbitrary units, respectively). Thus, these results strongly
suggest that the affinities of the two heterodimers for the p40 Rel
site are comparable.
Correlation Between Promoter Activity and DNA-Binding Activities. A
second test of the functional relevance of the p50yc-Rel, p50y
p65, and p50yp50 dimers was a comparison of their abilities to
bind a panel of p40 promoter mutants. Dimers that recognize the
nucleotides that contribute to promoter function would remain
viable candidates for the relevant activator of p40 transcription.
Previously, an analysis of a panel of 3- and 6-bp substitution
mutants spanning the p40 Rel site revealed that the critical
nucleotides for promoter activity in a transient transfection assay
extend from 2122 to 2131 (6). Using extracts from transfected
293T cells and probes containing the 3-bp mutations, gel shift
experiments were performed to monitor homodimer and het-
erodimer binding. The p50yc-Rel and p50yp65 complexes were
reduced by the four mutations that disrupt promoter activity
(Fig. 2C, lanes 2–5 and 9–12), but not by two mutations that alter
flanking sequences (lanes 1, 6, 8, and 13). In contrast, the p50
homodimer complex was consistently unaltered by the 2122y
2120 mutation, despite the substantial effect of this mutation on
promoter activity. The lack of a correlation between p50 ho-
modimer binding and promoter activity supports the hypothesis
that the p50 homodimer is unimportant for transcriptional
activation.
Interestingly, the 2122y2120 mutation had a relatively small
effect on binding by the p50yp65 and p50yc-Rel heterodimers,
although it reduced promoter activity to a greater extent than the
other mutations in the Rel site (lanes 5 and 12). A reasonable
explanation for the discrepancy between binding and promoter
activity is that the p50 homodimer preferentially binds this
mutant element, thereby suppressing promoter activity in a
dominant negative manner. Consistent with this hypothesis,
quantitation of the gel shift complexes revealed that the ho-
modimeryheterodimer ratio is enhanced by the 2122y2120
mutation (Fig. 2C, Bottom). (The modest 55% reduction in
promoter activity by the Rel-site mutations is a unique feature
of the transient transfection assay because Rel-site mutations
abolished promoter activity in a stable transfection assay; ref. 6.)
Comparable Transactivation Activities of p50yc-Rel and p50yp65. A
third common method for identifying the relevant Rel activator
Fig. 2. p50yp65 and p50yc-Rel bind the p40 Rel site with comparable
affinities. (A) 293T-cell extracts were prepared containing similar concentra-
tions of p50yfc-Rel and p50yfp65. Three concentrations of each extract were
analyzed by Western blot, using Flag and p50 antibodies. (B) The extracts were
analyzed by immunoprecipitation to determine the fraction of fc-Rel and fp65
associated with p50. Control extracts were also analyzed. Immunoprecipita-
tions were performed in the absence (lanes 1–8), and presence (lanes 9–20) of
p50 antibody. The immunoprecipitated portion (IP) and 25% of the superna-
tant (S) were analyzed by Western blot using Flag and p50 antibodies. Extracts
containing fp65 were adjusted by dilution so that comparable concentrations
of fp65 were present in each reaction. Extracts containing fc-Rel were also
adjusted. It is noteworthy the p50 antibody detected and precipitated the
293T-cell endogenous human p50 protein (e.g., lane 2), but did not copre-
cipitate detectable amounts of fc-Rel and fp65 in the absence of overex-
pressed murine p50. A likely explanation is that the endogenous human p50
was in fact present at a much lower concentration than the overexpressed
murine p50, but yielded a strong signal on the Western blots because the p50
antibody was raised against the human protein and presumably bound the
human protein with a higher affinity. (C) Gel shifts were performed with
extracts from 293T cells (4 mg) containing p50yfc-Rel (lanes 1–7) or p50yfp65
(lanes 8–14) complexes overexpressed to similar levels. Probes containing the
wild-type p40 Rel site (lanes 7 and 14) and various 3-bp mutations (lanes 1–6,
8–13) were analyzed. The effect of each mutation on promoter activity in a
transient transfection assay is indicated at the bottom (6). Also indicated is the
ratio of p50 homodimer to p50yfp65 or p50yfc-Rel heterodimer.
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of a promoter is to compare the abilities of overexpressed Rel
proteins to transactivate a promoter-reporter plasmid. These
experiments can be interpreted only if the relative concentra-
tions of overexpressed p65 and c-Rel are known. Therefore, fp65
and fc-Rel were used, with expression levels monitored by
Western blot. Overexpression of murine p50 by itself in 293T
cells resulted in a 10-fold transactivation of a p40 promoter-
luciferase reporter plasmid (Fig. 3, lanes 1 and 2). Inclusion of
increasing concentrations of an expression plasmid for either
fc-Rel or fp65 gradually enhanced transactivation, leading to
maximum transactivation of approximately 100-fold (lanes 3–6
and 11–14). Transactivation depended on the Rel site within the
p40 promoter because luciferase activity was greatly diminished
when a promoter-reporter plasmid containing a mutation in the
Rel site was used (lanes 7–10 and 15–18). Importantly, Western
blot analysis using Flag antibodies confirmed that comparable
concentrations of fc-Rel and fp65 were expressed (Fig. 3 Lower).
Similar results were obtained in three independent experiments
(data not shown). These results demonstrate that the p50yfc-Rel
and p50yfp65 heterodimers possess similar capacities for trans-
activation of a transfected p40 promoter.
One potential caveat of using the Flag-tagged proteins is that
the tag may alter their activities. To examine this possibility,
f lag-tagged and untagged p65 and c-Rel were compared. Similar
concentrations of p65 and fp65, as determined by Western blot
by using p65 antibodies, transactivated the p40 promoter to a
similar extent (data not shown). In addition, similar concentra-
tions of c-Rel and fc-Rel, as determined by Western blot by using
c-Rel antibodies, yielded similar transactivation results (data not
shown).
Selective Defect in IL-12 p40 Production in c-Rel2/2 Macrophages. The
above results suggest that both the p50yc-Rel and p50yp65
heterodimers may be capable of activating the endogenous p40
gene. Alternatively, family member specificity may not be man-
ifested in these assays. Rather, specificity may be observed only
when the Rel requirements are analyzed in a native chromatin
environment. To distinguish between these possibilities, p40
expression was examined in macrophages from mice lacking
specific Rel family members.
Thioglycollate-elicited peritoneal macrophages were isolated
from wild-type C57BLy6 mice and from c-Rel2/2, p502/2, and
p50yc-Rel2/2 mice (19, 20). Cytokine production was then
monitored by ELISA 24 h after stimulation with LPSyIFNg. The
results revealed a striking decrease in secreted p40 protein in the
c-Rel2/2 cells (Fig. 4A, Top Left). In five experiments, p40
protein was reduced between 43- and 1170-fold in activated
c-Rel2/2 cultures, with an average decrease of 235-fold (Fig. 4B,
Left). In contrast, the concentrations of IL-6, IL-1b, and TNF-a
were not significantly altered (Fig. 4A, Left). Production of the
anti-inflammatory cytokine, IL-10, was low but unaltered in the
c-Rel2/2 macrophages (Fig. 4A, Left). The unaltered production
of these cytokines demonstrates that cell activation proceeded
normally, suggesting that the p40 gene is a direct target of a
c-Rel-containing complex.
Consistent with the hypothesis that a p50yc-Rel heterodimer
is the relevant activator of p40 transcription, p40 concentrations
were reduced 15-fold in p502/2 peritoneal macrophages (Fig.
4A, Left)., In p50yc-Rel2/2 macrophages, p40 protein was un-
detectable (Fig. 4A, Left). In both of these strains, the other
cytokines were unaffected or were reduced to a modest extent.
The substantial expression of p40 in the p502/2 cells may be a
reflection of redundancy between p50 and p52 (A.H., unpub-
lished data).
To monitor the effect of the c-Rel deficiency on the expression
of Rel dimers, gel shift experiments were performed with the p40
probe and extracts from activated wild-type and c-Rel2/2 mac-
rophages. Abundant p50yp50, p50yp65, and p50yc-Rel com-
plexes were detected in wild-type extracts (Fig. 4C, lanes 1–5),
closely resembling the results obtained in J774 cells (Fig. 1). In
c-Rel2/2 extracts, the p50yp50 and p50yp65 complexes were
detected (lanes 6–10). However, the diffuse p50yc-Rel complex
was absent, as is most apparent from an examination of
the results in the presence of p65 antibodies (compare lanes 3
and 8).
To examine further the possibility that the p40 promoter is a
direct target of a c-Rel-containing complex, it was necessary to
analyze p40 production in p652/2 macrophages. This experiment
could not be performed with peritoneal macrophages because
disruption of the p65 gene results in embryonic lethality (21). We
therefore used macrophages differentiated in vitro from day-14.5
fetal liver cells (22). Activation of wild-type cells with LPSyIFNg
yielded p40, IL-6, IL-1b, and TNF-a at concentrations compa-
rable to those observed with the peritoneal macrophages (Fig.
4A, WT).
Fetal liver-derived macrophages from c-Rel2/2 mice pro-
duced p40 at greatly reduced concentrations (44-fold; Fig. 4 A
and B, Right). The most notable effect of the c-Rel deficiency
on the other cytokines was the 3- to 4-fold enhancement of
IL-10. Although IL-10 has been reported to suppress IL-12 p40
expression (23), the reduction in p40 expression in the
c-Rel2/2 cells appears to be independent of the IL-10 en-
hancement. First, IL-10 was not detected in supernatants from
c-Rel2/2 peritoneal macrophages, despite the reduction in p40
expression. Second, addition of IL-10 antibodies to the cul-
tured macrophages had no effect on p40 production (data not
shown). Third, IL-10 suppresses all of the proinf lammatory
cytokines shown here (24), yet IL-6 and TNF-a were unaf-
fected in the c-Rel2/2 cells.
In macrophages prepared from p652/2 fetal livers, the con-
centration of p40 protein was reduced by only 2-fold (Fig. 4 A and
B). Even this minor reduction probably overestimates the effect
on p40 expression because, when the supernatants were col-
lected for the ELISA, a large fraction of the p652/2 macrophages
appeared to be apoptotic under a light microscope. Therefore,
the reduced production of p40 and other cytokines may result,
Fig. 3. Comparable transactivation of a p40 promoter-reporter plasmid by
p50yp65 and p50yc-Rel. 293T cells were transfected with 2 mg of a wild-type
p40 promoter-luciferase reporter plasmid (ref. 6; lanes 1–6 and 11–14) or a
plasmid containing a Rel-site mutation (lanes 7–10 and 15–18). Reporter
plasmids were transfected alone (lanes 1, 7, and 15) or with a p50 expression
plasmid (0.1 mg; lane 2) and increasing amounts of fc-Rel (2–16 mg; lanes 3–6
and 8–10) or fp65 (0.2–1.6 mg; lanes 11–14 and 16–18) expression plasmids.
The fold-induction values were determined by dividing the luciferase activity
by the basal activity of the reporter alone (lane 1 for the wild-type and lanes
8 and 16 for the mutant constructs). fc-Rel, fp65, and p50 were monitored by
Western blot (Lower). The p50 detected in lanes 1, 7, and 15 corresponds to
endogenous human p50.
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at least in part, from cell death (that is presumably mediated by
TNF-a). These results support the hypothesis that a c-Rel-
containing complex is an essential activator of p40 transcription.
Analysis of Cytokine mRNAs. To determine whether the ELISA
results reflect differences in steady-state mRNAs, total RNA
was prepared from wild-type and mutant peritoneal and fetal
liver-derived macrophages before and after activation with LPSy
IFN-g for 4 h. A comparison of RNase protection assay results
revealed a close correlation with the ELISA results (Fig. 5).
IL-12 p40 mRNA was reduced to nearly undetectable levels in
the c-Rel2/2 cells, whereas IL-1b, IL-6, and TNFa mRNAs were
unaffected. The most significant difference between the ELISA
and RNase protection results was that, in p652/2 macrophages
from fetal liver, p40 mRNA was consistently reduced to a greater
extent (approximately 10-fold) than was p40 protein (Fig. 5B).
The reason for this difference is unknown, but because the
mRNAs for almost all of the genes monitored are substantially
reduced in the apoptotic p652/2 macrophages, this reduction
may be because of a general effect of the p65 deficiency on cell
growth and viability.
Discussion
This study revealed much greater selectivity in the Rel-protein
requirements for expression of a proinflammatory cytokine gene
than was anticipated. The biological significance of the c-Rel
requirement for p40 expression remains to be determined.
Although p40 transcription is regulated by many of the same
inducers and antiinflammatory agents as other proinflammatory
cytokine genes, it is uniquely regulated by a number of agents,
whose mechanisms of action may depend on c-Rel (2, 3, 25).
IFN-g is a prominent example of an agent that enhances p40
expression, with relatively little effect on other proinflammatory
cytokines (3, 25). However, c-Rel is not required solely for IFN-g
responsiveness because the c-Rel requirement was observed on
LPS stimulation in the absence of IFN-g (data not shown).
Another unique feature of p40 induction is its requirement for
new protein synthesis (20, 24). Furthermore, p40 is expressed in
immature cells of the myeloid lineage as well as in mature
Fig. 4. A selective defect in IL-12 p40 production in c-Rel2/2 macrophages. (A)
Cytokine expression by peritoneal (Left) or fetal-liver (Right) macrophages
was monitored by ELISA. Error bars represent the range of results rather than
the standard deviation. (B) The p40 ELISA data from each sample analyzed
during this study are shown (E). TheF indicate the average. (C) Gel shift assays
were performed with extracts from wild-type (lanes 1–5) and c-Rel2/2 (lanes
6–10) peritoneal macrophages activated with LPSyIFN-g for 4 h.
Fig. 5. Steady-state mRNA levels in wild-type and Rel-deficient macro-
phages. Total RNA was isolated from peritoneal (A) and fetal liver-derived (B)
macrophages before and 4 h after activation with LPSyIFN-g. Specific mRNA
levels were determined by RNase protection. The data shown correspond only
to the cytokine mRNAs analyzed by ELISA in Fig. 4.
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macrophages, whereas TNF-a and IL-1b are expressed only in
mature macrophages (26). The c-Rel requirement may be re-
lated to one of these unique features of p40 regulation or to many
others that have been reported (25).
It is most intriguing to consider the possibility that the c-Rel
requirement may be related to IL-12’s unique biological role as
an inducer of T helper 1 cell differentiation (2, 3). This function
would be reminiscent of the selective functions of Rel proteins
in Drosophila, where the expression of antifungal and antibac-
terial peptides exhibit different Rel-protein requirements (27,
28). In some respects, the IL-12 p40 gene in mammals is
analogous to the antifungal and antibacterial genes in Drosophila
because its expression is required for an effective immune
response against a specific subset of pathogens (in particular,
intracellular pathogens). The data therefore suggest a potential
parallel between Drosophila and mammals; in these distantly
related organisms, unusually strong requirements for specific
Rel family members appear to be associated with the induction
of pathogen-specific genes.
The c-Rel requirement for p40 transcription is most likely
because of an essential interaction between a c-Rel-containing
complex (presumably a p50yc-Rel dimer) and the Rel site within
the p40 promoter. This hypothesis is based on the following
reasoning: First, the in vitro DNA-binding studies provided
evidence that the only abundant dimers in activated macro-
phages capable of binding the p40 Rel site are p50yp50, p50yp65,
and p50yc-Rel. The p50 homodimer is unlikely to be an essential
activator because p50 lacks a transactivation domain and does
not recognize all of the nucleotides that are important for
promoter function (i.e., 2122; see Fig. 2C). The p50yp65 dimer
can transactivate the promoter in transfection assays, but p40
mRNA and protein remain quite abundant in p652/2 macro-
phages, despite the apoptotic phenotype of these cells. In
contrast, p40 mRNA and protein are reduced to nearly unde-
tectable levels in c-Rel2/2 macrophages.
If a p50yc-Rel dimer is truly required for the activity of the Rel
site within the p40 promoter, the mechanistic basis of selectivity
may be difficult to elucidate. A likely explanation for the lack of
selectivity in the DNA-binding assays is that differential binding
affinities are not responsible for the c-Rel requirement. Fur-
thermore, the c-Rel requirement does not appear to be because
of differences in the intrinsic transactivation activities of p50y
p65 and p50yc-Rel. Although selective transactivation of the p40
promoter by c-Rel was observed in a previous study (4), the p65
and c-Rel expression levels were not compared. Most likely, it
will be necessary to study the promoter in its native chromosomal
environment to elucidate the mechanistic basis of selectivity.
c-Rel may carry out a selective interaction with another DNA-
binding protein, coactivator complex, or general transcription
factor that is required for promoter activity, but only when the
promoter is in a native chromosomal context.
Although the current data suggest an essential role for a
c-Rel-containing complex at the p40 promoter, they do not rule
out the possibility that p50yp65 and p50yc-Rel complexes are
equally competent for activation of the endogenous promoter,
with an essential c-Rel interaction occurring elsewhere in the
locus. The current data also do not rule out the possibility that
the c-Rel requirement for p40 transcription is indirect. Although
this possibility cannot be excluded until the mechanistic basis of
the c-Rel requirement is fully understood, it seems unlikely,
given the highly specific effect of the c-Rel deficiency.
In conclusion, the selective defect in IL-12 p40 transcription
in c-Rel2/2 macrophages provides a rare opportunity to examine
the mechanistic basis of Rel family member selectivity. By
introducing c-Rel mutants and c-Relyp65 chimeras into the
c-Rel2/2 macrophages, it should be possible to determine the
domains of c-Rel that are responsible for the selectivity, leading
to the proteins that interact with the selectivity domains. Future
analyses of the properties of p40 regulation also may reveal the
biological significance of the selectivity.
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